Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,156 | 40,850 | 42,445 | 43,939 | 46,437 |
| Other current assets | 599 | 852 | 254 | 611 | 1,218 |
| TOTAL | $40,755 | $41,702 | $42,699 | $44,550 | $47,655 |
| Non-Current Assets | |||||
| PPE Net | 17 | 21 | 25 | 30 | 37 |
| Other Non-Current Assets | 311 | 336 | 361 | 385 | 409 |
| TOTAL | $328 | $357 | $386 | $415 | $446 |
| Total Assets | $41,083 | $42,059 | $43,085 | $44,965 | $48,101 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 241 | 366 | 334 | 593 | 1,110 |
| Accrued Expenses | 1,361 | 900 | 798 | 1,344 | 1,699 |
| TOTAL | $1,602 | $1,266 | $1,132 | $1,937 | $2,809 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 243 | 262 | 280 | 301 | 329 |
| TOTAL | $243 | $262 | $280 | $301 | $329 |
| Total Liabilities | $1,845 | $1,528 | $1,412 | $2,238 | $3,138 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 |
| Common Shares | 14 | 14 | 14 | 14 | 14 |
| Retained earnings | -186,228 | -184,748 | -183,402 | -182,228 | -179,895 |
| TOTAL | $39,238 | $40,531 | $41,673 | $42,727 | $44,963 |
| Total Liabilities And Equity | $41,083 | $42,059 | $43,085 | $44,965 | $48,101 |